GoWest is Gothenburg’s and west Sweden’s annual venture capital forum for investors, startups and scaleups!

Who is attending GoWest?

• Startups and scaleups looking for pre-seed, seed and series A investments
• Business angels, venture capital firms, family offices and private investors and Gothenburg’s wider investor community
• Industry representatives

More Info

Speakers 2023

Speaker 2023
Patrik Andersson
CEO
Business Region Göteborg

Speaker 2023
Virginia E. Vegas
Managing Director
VC Challenge

Moderator 2023
Anna Ljungdahl
Investment Director & Head of Sustainable investments
Industrifonden

Speaker 2023
Tim He
Partner
Summa Equity

And Many More!

What does GoWest offer?

Access to the online match-making tool to enable you to meet startups, investors and industry

The chance to join a range of panel discussions, catch up on trends and gain valuable insights

The opportunity to connect with your peers and build a stronger network

Startups

Fundraising is the answer to WHY the early stage ecosystem meets. The match-making platform enables people to find connections and engage online and IRL during and after the conference while the pitch sessions help startups improve their visibility and broaden their network. You can also catch up on trends and gain valuable insights and connect with your peers and build a stronger network at the conference.

Investors

Investors will have access to a great deal-flow of international startups, particularly deep-tech startups, from west Sweden. The match-making platform enables investors to find and engage with startups online and IRL during and after the conference while the exclusive investor mixer event enables investors to connect with each other.

Industry & Community

The region is chacterized by its industrial heritage and reputation for cutting edge research at universities and hospitals and green urban development. The startup community consists of 8 incubators, accelerators and science parks. Gothenburg is home to global brands such as Volvo, SKF, Ericsson and AstraZeneca.